NATIONAL HEALTHCARE CORP (NHC) Fundamental Analysis & Valuation

NYSEARCA:NHC • US6359061008

Current stock price

173.29 USD
-1.78 (-1.02%)
At close:
173.29 USD
0 (0%)
After Hours:

This NHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHC Profitability Analysis

1.1 Basic Checks

  • NHC had positive earnings in the past year.
  • In the past year NHC had a positive cash flow from operations.
  • Each year in the past 5 years NHC has been profitable.
  • NHC had a positive operating cash flow in each of the past 5 years.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • NHC's Return On Assets of 7.86% is amongst the best of the industry. NHC outperforms 90.00% of its industry peers.
  • NHC has a better Return On Equity (11.23%) than 75.00% of its industry peers.
  • NHC's Return On Invested Capital of 7.58% is fine compared to the rest of the industry. NHC outperforms 72.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NHC is below the industry average of 8.40%.
  • The last Return On Invested Capital (7.58%) for NHC is above the 3 year average (5.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.86%
ROE 11.23%
ROIC 7.58%
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • NHC has a Profit Margin of 7.91%. This is amongst the best in the industry. NHC outperforms 89.00% of its industry peers.
  • In the last couple of years the Profit Margin of NHC has grown nicely.
  • Looking at the Operating Margin, with a value of 8.46%, NHC is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
  • NHC's Operating Margin has declined in the last couple of years.
  • The Gross Margin of NHC (39.31%) is better than 71.00% of its industry peers.
  • In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
Industry RankSector Rank
OM 8.46%
PM (TTM) 7.91%
GM 39.31%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHC is destroying value.
  • The number of shares outstanding for NHC has been increased compared to 1 year ago.
  • NHC has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NHC has been reduced compared to a year ago.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • NHC has an Altman-Z score of 5.78. This indicates that NHC is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of NHC (5.78) is better than 88.00% of its industry peers.
  • The Debt to FCF ratio of NHC is 0.27, which is an excellent value as it means it would take NHC, only 0.27 years of fcf income to pay off all of its debts.
  • NHC's Debt to FCF ratio of 0.27 is amongst the best of the industry. NHC outperforms 91.00% of its industry peers.
  • NHC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • NHC has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. NHC outperforms 82.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Altman-Z 5.78
ROIC/WACC0.84
WACC8.97%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that NHC should not have too much problems paying its short term obligations.
  • NHC's Current ratio of 1.82 is fine compared to the rest of the industry. NHC outperforms 75.00% of its industry peers.
  • NHC has a Quick Ratio of 1.79. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.79, NHC is doing good in the industry, outperforming 76.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.79
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.38% over the past year.
  • The Earnings Per Share has been growing by 23.00% on average over the past years. This is a very strong growth
  • The Revenue has grown by 16.09% in the past year. This is quite good.
  • The Revenue has been growing by 8.10% on average over the past years. This is quite good.
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

Find the best growth stocksShow best growing peers

3

4. NHC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.59 indicates a rather expensive valuation of NHC.
  • Based on the Price/Earnings ratio, NHC is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of NHC to the average of the S&P500 Index (26.77), we can say NHC is valued inline with the index average.
Industry RankSector Rank
PE 22.59
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 61.00% of the companies in the same industry are more expensive than NHC, based on the Enterprise Value to EBITDA ratio.
  • NHC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NHC is cheaper than 61.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.19
EV/EBITDA 13.58
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.98
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. NHC Dividend Analysis

5.1 Amount

  • NHC has a Yearly Dividend Yield of 1.50%.
  • Compared to an average industry Dividend Yield of 0.46, NHC pays a better dividend. On top of this NHC pays more dividend than 89.00% of the companies listed in the same industry.
  • NHC's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.5%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.74%.
  • NHC has paid a dividend for at least 10 years, which is a reliable track record.
  • NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.74%
Div Incr Years12
Div Non Decr Years12
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 32.25% of the earnings are spent on dividend by NHC. This is a low number and sustainable payout ratio.
  • NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.25%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHC Fundamentals: All Metrics, Ratios and Statistics

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (4/30/2026, 8:07:39 PM)

After market: 173.29 0 (0%)

173.29

-1.78 (-1.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength54.66
Industry Growth63.98
Earnings (Last)02-25
Earnings (Next)05-01
Inst Owners64.99%
Inst Owner Change0.23%
Ins Owners7.1%
Ins Owner Change0.95%
Market Cap2.70B
Revenue(TTM)1.52B
Net Income(TTM)120.02M
Analysts60
Price TargetN/A
Short Float %6.05%
Short Ratio6.45
Dividend
Industry RankSector Rank
Dividend Yield 1.5%
Yearly Dividend2.5
Dividend Growth(5Y)3.74%
DP32.25%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-31
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.59
Fwd PE N/A
P/S 1.78
P/FCF 18.19
P/OCF 14.61
P/B 2.53
P/tB 3.08
EV/EBITDA 13.58
EPS(TTM)7.67
EY4.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.53
FCFY5.5%
OCF(TTM)11.86
OCFY6.85%
SpS97.29
BVpS68.51
TBVpS56.31
PEG (NY)N/A
PEG (5Y)0.98
Graham Number108.735 (-37.25%)
Profitability
Industry RankSector Rank
ROA 7.86%
ROE 11.23%
ROCE 10.08%
ROIC 7.58%
ROICexc 9.49%
ROICexgc 11.67%
OM 8.46%
PM (TTM) 7.91%
GM 39.31%
FCFM 9.79%
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
ROICexc(3y)6.91%
ROICexc(5y)6.01%
ROICexgc(3y)8.5%
ROICexgc(5y)7.43%
ROCE(3y)7.43%
ROCE(5y)6.42%
ROICexgc growth 3Y57.26%
ROICexgc growth 5Y3.29%
ROICexc growth 3Y57.83%
ROICexc growth 5Y-0.34%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
F-Score9
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Debt/EBITDA 0.19
Cap/Depr 81.14%
Cap/Sales 2.4%
Interest Coverage 18.26
Cash Conversion 106.81%
Profit Quality 123.85%
Current Ratio 1.82
Quick Ratio 1.79
Altman-Z 5.78
F-Score9
WACC8.97%
ROIC/WACC0.84
Cap/Depr(3y)71.08%
Cap/Depr(5y)76.94%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.68%
Profit Quality(3y)108.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.78%
EBIT growth 3Y64.7%
EBIT growth 5Y5.71%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.48%
FCF growth 3YN/A
FCF growth 5Y-3.9%
OCF growth 1Y72.48%
OCF growth 3Y176.64%
OCF growth 5Y-1.86%

NATIONAL HEALTHCARE CORP / NHC Fundamental Analysis FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Overvalued.


Can you provide the profitability details for NATIONAL HEALTHCARE CORP?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 7 / 10.


What is the valuation of NATIONAL HEALTHCARE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NATIONAL HEALTHCARE CORP (NHC) is 22.59 and the Price/Book (PB) ratio is 2.53.


Can you provide the financial health for NHC stock?

The financial health rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10.